Bariatric Surgery versus intensive medical therapy for diabetes [2]

New England Journal of Medicine

Volumn 371, Issue 7, 2014, Pages 680-681

  Sypek, Matthew ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXALIC ACID; ANTIDIABETIC AGENT;

ALBUMIN TO CREATININE RATIO; BARIATRIC SURGERY; BODY MASS; DIABETES MELLITUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INTENSIVE CARE; INTERMETHOD COMPARISON; KIDNEY DISEASE; KIDNEY FUNCTION; LETTER; OBESITY; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; STOMACH SURGERY; URINARY EXCRETION; FEMALE; GASTRECTOMY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; STOMACH BYPASS;

DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; HUMANS; HYPOGLYCEMIC AGENTS; MALE;

EID: 84906081337     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1407393     Document Type: Letter

References (4)

1. Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg 2010;211:8-15.
2. Matlaga BR, Shore AD, Magnuson T, Clark JM, Johns R, Makary MA. Effect of gastric bypass surgery on kidney stone disease. J Urol 2009;181:2573-7.
3. Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery 2011;149:654-61.
4. Nasr SH, D'Agati VD, Said SM, et al. Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 2008;3:1676-83.